Luts & Greenleigh Group’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Sell
1,675
-8
-0.5% -$2.87K 0.44% 43
2025
Q4
$592K Sell
1,683
-41
-2% -$14.9K 0.5% 41
2025
Q3
$637K Buy
1,724
+7
+0.4% +$2.7K 0.57% 37
2025
Q2
$679K Buy
1,717
+7
+0.4% +$2.62K 0.65% 36
2025
Q1
$637K Sell
1,710
-1
-0.1% -$381 0.63% 34
2024
Q4
$616K Buy
1,711
+42
+3% +$15.6K 0.61% 36
2024
Q3
$603K Buy
1,669
+9
+0.5% +$3.11K 0.58% 35
2024
Q2
$565K Buy
+1,660
New +$562K 0.59% 34
2023
Q4
$479K Hold
1,600
0.6% 32
2023
Q3
$437K Hold
1,600
0.54% 35
2023
Q2
$488K Hold
1,600
0.6% 35
2023
Q1
$457K Sell
1,600
-488
-23% -$129K 0.58% 35
2022
Q4
$510K Buy
+2,088
New +$474K 0.65% 30

Other funds holding SYK

Luts & Greenleigh Group's SYK Position: Q1 2026 in Review

Luts & Greenleigh Group reduced its Stryker (SYK) stake by 0.48% in Q1 2026, selling an estimated $2.87K and leaving 1,675 shares worth $550K. The position accounts for 0.44% of the portfolio, ranked #43.

Luts & Greenleigh Group first reported a position in SYK in Q4 2022 and has held it in 13 quarters since. The position peaked at $679K in Q2 2025. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Luts & Greenleigh Group held 1,675 shares of Stryker worth $550K as of Q1 2026.
  • Luts & Greenleigh Group sold 8 Stryker shares in Q1 2026, an estimated $2.87K.
  • Stryker made up 0.44% of Luts & Greenleigh Group's portfolio in Q1 2026, its #43 holding.
  • Luts & Greenleigh Group first reported a position in Stryker in Q4 2022 and has held it in 13 quarters since.
  • Luts & Greenleigh Group's Stryker position peaked at $679K in Q2 2025.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Luts & Greenleigh Group's 13F filing for Q1 2026, filed 5 May 2026.